Roche obesity drug shows 15.5% weight loss in diabetes trial
Investing.com· Investing.com· Sep 22, 2026 · 11:25 AM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocks42 minutes ago
Nintendo Switch 2 sales plunge 41% as price hikes and memory crunch bite
Sales of Nintendo's flagship Switch 2 plunged in its fiscal second quarter after the Japanese gaming giant rolled out price hikes amid soaring memory costs.
CNBC Stocks
stocks43 minutes ago
IMCD third quarter earnings rise 18% to €140.2 million
Investing.com
stocks44 minutes ago
Sony posts 45% Q2 profit rise on movies, games boost
Investing.com